Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis
Massimo Filippi(Vita-Salute San Raffaele University), D. H. Miller(Pacific Environment), D. W. Paty(Multiple Sclerosis Society), Alan C. Evans(Montreal Neurological Institute and Hospital), Paul S. Tofts(Brighton and Sussex Medical School), Henry F. McFarland(Unknown), Paolo Bruzzi(Alleanza Contro il Cancro), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Jerry S. Wolinsky(The University of Texas Health Science Center at Houston), Joseph A. Frank(National Institutes of Health), P. D. Molyneux(UCL Australia), Robert I. Grossman(New York University), H.J. Adèr(University of Amsterdam), Jack H. Simon(University of Colorado Health), Mark A. Horsfield(IRCCS Ospedale San Raffaele)
Cited by 171
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Brain development during childhood and adolescence: a longitudinal MRI study
|Nature Neuroscience|1999|5.6k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k